Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 1/20 | 0.31 |
| ▸ | FNTB | P49356 | 1/20 | 0.31 |
| ▸ | MAT2A | P31153 | 3/20 | 0.31 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | MAP3K14 | Q99558 | 2/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24721442 | 1.00 | FNTA (0.31) | FNTAFNTBMAT2APRMT5CYP1A2 | |
| SCHEMBL23576786 | 1.00 | FNTA (0.31) | FNTAFNTBMAT2APRMT5CYP1A2 | |
| SCHEMBL29909594 | 1.00 | FNTA (0.31) | FNTAFNTBMAT2APRMT5CYP1A2 | |
| SCHEMBL23576784 | 1.00 | FNTA (0.31) | FNTAFNTBMAT2APRMT5CYP1A2 | |
| SCHEMBL23601039 | 0.91 | PTGES (0.36) | FNTAFNTBMAT2APRMT5CYP1A2 | |
| SCHEMBL23601829 | 0.90 | MAP3K14 (0.32) | FNTAFNTBMAT2APRMT5CYP1A2 | |
| SCHEMBL29909004 | 0.89 | FNTA (0.32) | FNTAFNTBMAP3K14 | |
| SCHEMBL23601290 | 0.89 | FNTA (0.32) | FNTAFNTBMAP3K14 | |
| SCHEMBL23601040 | 0.89 | FNTA (0.34) | FNTAFNTBMAT2APRMT5CYP1A2 | |
| SCHEMBL23576764 | 0.88 | FNTA (0.31) | FNTAFNTBMAP3K14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4081305-A1 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | Carna Biosciences, Inc. (JP) | 2022-11-02 | — | — | EP | disclosed |